Skip to Main Content

Author Details

Mirit I Aladjem
National Cancer Institute, Center for Cancer Research
1988
129
40
PMIDPaper TitleJournal TitlePublished Year
36715552Extrachromosomal DNA Amplification Contributes to Small Cell Lung Cancer Heterogeneity and Is Associated with Worse Outcomes.Cancer Discov2023
37824137Berzosertib Plus Topotecan vs Topotecan Alone in Patients With Relapsed Small Cell Lung Cancer: A Randomized Clinical Trial.JAMA Oncol2023
37998365SIRT1 Prevents R-Loops during Chronological Aging by Modulating DNA Replication at rDNA Loci.Cells2023
37612584RepID represses megakaryocytic differentiation by recruiting CRL4A-JARID1A at DAB2 promoter.Cell Commun Signal2023
37216280Schlafen 11 (SLFN11) Kills Cancer Cells Undergoing Unscheduled Re-replication.Mol Cancer Ther2023
36715552Extrachromosomal DNA Amplification Contributes to Small Cell Lung Cancer Heterogeneity and Is Associated with Worse Outcomes.Cancer Discov2023
37461562RepID represses megakaryocytic differentiation by recruiting CRL4A-JARID1A at DAB2 promoter.Res Sq2023
36924503Matrin3 regulates mitotic spindle dynamics by controlling alternative splicing of CDC14B.Cell Rep2023
37227187Targeting Replication Stress and Chemotherapy Resistance with a Combination of Sacituzumab Govitecan and Berzosertib: A Phase I Clinical Trial.Clin Cancer Res2023
37998365SIRT1 Prevents R-Loops during Chronological Aging by Modulating DNA Replication at rDNA Loci.Cells2023
37612584RepID represses megakaryocytic differentiation by recruiting CRL4A-JARID1A at DAB2 promoter.Cell Commun Signal2023
37824137Berzosertib Plus Topotecan vs Topotecan Alone in Patients With Relapsed Small Cell Lung Cancer: A Randomized Clinical Trial.JAMA Oncol2023
37216280Schlafen 11 (SLFN11) Kills Cancer Cells Undergoing Unscheduled Re-replication.Mol Cancer Ther2023
37227187Targeting Replication Stress and Chemotherapy Resistance with a Combination of Sacituzumab Govitecan and Berzosertib: A Phase I Clinical Trial.Clin Cancer Res2023
37461562RepID represses megakaryocytic differentiation by recruiting CRL4A-JARID1A at DAB2 promoter.Res Sq2023
36924503Matrin3 regulates mitotic spindle dynamics by controlling alternative splicing of CDC14B.Cell Rep2023
34625299Preventing excess replication origin activation to ensure genome stability.Trends Genet2022
35463463DNA replication profiling by molecular combing on single DNA fibers.STAR Protoc2022
35524559Convergence of SIRT1 and ATR signaling to modulate replication origin dormancy.Nucleic Acids Res2022
36368157The differentially expressed gene signatures of the Cullin 3-RING ubiquitin ligases in neuroendocrine cancer.Biochem Biophys Res Commun2022
35387667Targeting selenoprotein H in the nucleolus suppresses tumors and metastases by Isovalerylspiramycin I.J Exp Clin Cancer Res2022
36093297Combined epigenetic and immunotherapy for blastic and classical mantle cell lymphoma.Oncotarget2022
36342127Context-Dependent Function of Long Noncoding RNA <i>PURPL</i> in Transcriptome Regulation during p53 Activation.Mol Cell Biol2022
36325065Integrative epigenomic analyses of small cell lung cancer cells demonstrates the clinical translational relevance of gene body methylation.iScience2022
36381660Replication stress defines distinct molecular subtypes across cancers.Cancer Res Commun2022
34625299Preventing excess replication origin activation to ensure genome stability.Trends Genet2022
35217604BEND3 safeguards pluripotency by repressing differentiation-associated genes.Proc Natl Acad Sci U S A2022
35463463DNA replication profiling by molecular combing on single DNA fibers.STAR Protoc2022
35524559Convergence of SIRT1 and ATR signaling to modulate replication origin dormancy.Nucleic Acids Res2022
35387667Targeting selenoprotein H in the nucleolus suppresses tumors and metastases by Isovalerylspiramycin I.J Exp Clin Cancer Res2022
36342127Context-Dependent Function of Long Noncoding RNA <i>PURPL</i> in Transcriptome Regulation during p53 Activation.Mol Cell Biol2022
36368157The differentially expressed gene signatures of the Cullin 3-RING ubiquitin ligases in neuroendocrine cancer.Biochem Biophys Res Commun2022
36381660Replication stress defines distinct molecular subtypes across cancers.Cancer Res Commun2022
36093297Combined epigenetic and immunotherapy for blastic and classical mantle cell lymphoma.Oncotarget2022
36325065Integrative epigenomic analyses of small cell lung cancer cells demonstrates the clinical translational relevance of gene body methylation.iScience2022
35217604BEND3 safeguards pluripotency by repressing differentiation-associated genes.Proc Natl Acad Sci U S A2022
33468559Genome-Wide Analysis Unveils DNA Helicase RECQ1 as a Regulator of Estrogen Response Pathway in Breast Cancer Cells.Mol Cell Biol2021
33857330Switching DCAFs: Beyond substrate receptors.Bioessays2021
33539925SIRT1 stabilizes extrachromosomal gene amplification and contributes to repeat-induced gene silencing.J Biol Chem2021
34171797Molecular double clips within RepID WD40 domain control chromatin binding and CRL4-substrate assembly.Biochem Biophys Res Commun2021
33848478Therapeutic targeting of ATR yields durable regressions in small cell lung cancers with high replication stress.Cancer Cell2021
34112784The epigenetic regulator LSH maintains fork protection and genomic stability via MacroH2A deposition and RAD51 filament formation.Nat Commun2021
33468559Genome-Wide Analysis Unveils DNA Helicase RECQ1 as a Regulator of Estrogen Response Pathway in Breast Cancer Cells.Mol Cell Biol2021
34103496Dynamics of replication origin over-activation.Nat Commun2021
33196823CellMiner Cross-Database (CellMinerCDB) version 1.2: Exploration of patient-derived cancer cell line pharmacogenomics.Nucleic Acids Res2021
33334821The p53-induced RNA-binding protein ZMAT3 is a splicing regulator that inhibits the splicing of oncogenic CD44 variants in colorectal carcinoma.Genes Dev2021
34745220Encounters in Three Dimensions: How Nuclear Topology Shapes Genome Integrity.Front Genet2021
34828271Histone Variant H2A.J Is Enriched in Luminal Epithelial Gland Cells.Genes (Basel)2021
34645815BRCA2 associates with MCM10 to suppress PRIMPOL-mediated repriming and single-stranded gap formation after DNA damage.Nat Commun2021
33848478Therapeutic targeting of ATR yields durable regressions in small cell lung cancers with high replication stress.Cancer Cell2021
  • 1 - 50 of 258

Recommended Authors

Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital
Career Start Year 2012
Number of shared co-authors 0
Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital
Career Start Year 2010
Number of shared co-authors 0
CNRS, Universite de Toulouse
Career Start Year 2009
Number of shared co-authors 0
Karolinska Institutet
Career Start Year 2005
Number of shared co-authors 1
CNRS, Universite de Toulouse
Career Start Year 2002
Number of shared co-authors 0
Leiden University Medical Center
Career Start Year 2001
Number of shared co-authors 1
Novo Nordisk Foundation Center for Protein Research, University of Copenhagen
Career Start Year 1999
Number of shared co-authors 0
Dana-Farber Cancer Institute
Career Start Year 1999
Number of shared co-authors 4
The University of Sheffield
Career Start Year 1998
Number of shared co-authors 2
Friedrich Miescher Institute for Biomedical Research
Career Start Year 1997
Number of shared co-authors 0
Institute for Cancer Genetics, Columbia University Irving Medical Center
Career Start Year 1997
Number of shared co-authors 0
The Francis Crick Institute
Career Start Year 1996
Number of shared co-authors 0
The Lunenfeld-Tannenbaum Research Institute, Mount Sinai Hospital
Career Start Year 1995
Number of shared co-authors 1
Polytechnic Institute of Leiria
Career Start Year 1994
Number of shared co-authors 2
Stowers Institute for Medical Research
Career Start Year 1992
Number of shared co-authors 1
Center for Public Health Genomics, University of Virginia
Career Start Year 1991
Number of shared co-authors 0
Sanford Burnham Prebys Medical Discovery Institute
Career Start Year 1991
Number of shared co-authors 0
University of Toronto, 1 King's College Circle
Career Start Year 1991
Number of shared co-authors 2
National Institute of Child Health & Human Development, National Institutes of Health
Career Start Year 1991
Number of shared co-authors 0
Panum Institute, University of Copenhagen
Career Start Year 1990
Number of shared co-authors 0
Mission Therapeutics Ltd. Glenn Berge Building
Career Start Year 1987
Number of shared co-authors 2
Friedrich Miescher Institute for Biomedical Research
Career Start Year 1984
Number of shared co-authors 0
Institute of Cancer Genetics, Columbia University Irving Medical Center
Career Start Year 1983
Number of shared co-authors 0
L'Institut Suisse de Recherche Experimentale sur le Cancer (ISREC) Foundation
Career Start Year 1982
Number of shared co-authors 0
Howard Hughes Medical Institute, Brigham and Women's Hospital, Harvard Medical School
Career Start Year 1982
Number of shared co-authors 2
University of Cambridge, Hutchison Research Centre
Career Start Year 1982
Number of shared co-authors 1
HHMI/NYU Langone School of Medicine
Career Start Year 1980
Number of shared co-authors 0
Columbia University Vagelos College of Physicians & Surgeons
Career Start Year 1977
Number of shared co-authors 1
University of California berkeley
Career Start Year 1970
Number of shared co-authors 0
University of Michigan ann arbor
Career Start Year 1955
Number of shared co-authors 1

Collaborators

Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 40
Center for Cancer Research, National Cancer Institute
Co-authored papers 29
Center for Cancer Research, National Cancer Institute
Co-authored papers 18
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 16
Harvard Medical School
Co-authored papers 11
Center for Cancer Research
Co-authored papers 9
The University of Texas MD Anderson Cancer Center
Co-authored papers 9
Co-authored papers 7
The University of Texas MD Anderson Cancer Center
Co-authored papers 7
Center for Cancer Research, National Cancer Institute
Co-authored papers 7
Albert Einstein College of Medicine
Co-authored papers 7
College of Computing and Informatics, University of North Carolina at Charlotte
Co-authored papers 6
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 6
National Cancer Institute, National Institutes of Health
Co-authored papers 5
Inc., Frederick National Laboratory for Cancer Research
Co-authored papers 4
Center for Cancer Research, National Cancer Institute
Co-authored papers 4
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 3
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 3
Center for Cancer Research, National Cancer Institute
Co-authored papers 3
National Institute on Aging (NIA), National Institutes of Health (NIH)
Co-authored papers 3
Meharry Medical College
Co-authored papers 3
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 3
The National Institutes of Health
Co-authored papers 3
Broad Institute of MIT and Harvard
Co-authored papers 3
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 3
National Institute for Arthritis and Musculoskeletal and Skin Disease
Co-authored papers 2
Bilkent University
Co-authored papers 2
Co-authored papers 2
Albert Einstein College of Medicine
Co-authored papers 2
University of Texas Southwestern Medical Center at Dallas
Co-authored papers 2